Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master TrialAmy Burd, John C. Byrd, Uma Borate et al.|Nature Medicine|2020Cited by 195
Clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (SCH 727965) in acute leukemiasIvana Gojo, Rajat Bannerji, Mariola Sadowska et al.|Cancer Chemotherapy and Pharmacology|2013Cited by 94